Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
Eur J Med Chem
; 43(8): 1774-80, 2008 Aug.
Article
em En
| MEDLINE
| ID: mdl-18045742
ABSTRACT
[1,2,3]-Triazole derivatives of nor-beta-lapachone were synthesized and assayed against the infective bloodstream trypomastigote form of Trypanosoma cruzi, the etiological agent of Chagas disease. All the derivatives were more active than the original quinones, with IC(50)/1 day values in the range of 17 to 359 microM, the apolar phenyl substituted triazole 6 being the most active compound. These triazole derivatives of nor-beta-lapachone emerge as interesting new lead compounds in drug development for Chagas disease.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Triazóis
/
Tripanossomicidas
/
Trypanosoma cruzi
/
Naftoquinonas
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article